Information Density: Resilience – Signal Evidence & AI Readability

[H1] Make your complex medicine here with confidence.

At Resilience, we deliver therapeutics manufactured with excellence, quality, and reliability to our partners and the patients whose lives depend on them.
More about us

[IMG: Resilience key art graphic]

[H2] Nothing in this industry ever stays the same. So we've evolved too.
We've expanded our strengths while keeping quality, speed, and sustainability front and center to build a more resilient tomorrow, today. Resilience is bringing together brilliant minds in science and engineering with access to advanced technologies and right-first-time performance at scale.

[H2] Facilities
Resilience is North America based, with facilities across the continental US and Canada. Our regulatory expertise spans across global markets and serves customers in the EU, Asia, the Middle East, and North America.
See our sites

[IMG: resi-arrow-white]

[H2] Custom solutions to fit your needs

We were founded with a straightforward yet bold purpose: to broaden access to complex medicines and to protect biopharmaceutical supply chains against disruption. At the heart of our approach is a network of high-tech, end-to-end drug substance and drug product manufacturing solutions that can help ensure the medicines of today and tomorrow can be made quickly, safely, sustainably, and at scale.

Large Molecule Biologics Development & Manufacturing

Cell Therapy Development & Manufacturing

Aseptic Drug Product Manufacturing

Device Assembly, Packaging & Logistics

*Photo captured in aseptic training environment.

[H2] Earning Trust One Dose at a Time

Our dedication to quality drives everything we do. Our unwavering commitment comes to life through the delivery of more than 100 million vials and pre-filled syringes each year.
[H3] Commercial readiness
100% pass rate for third-party and EU Annex 1 assessments.
[H3] Successful inspections

USFDA cGMP

USFDA PAI

USFDA PFS & Vial Approval

Health Canada

EMA Virtual Inspection

[IMG: RESI-24-003d-3DKA-_-08-DS_Pesrp01_WF_black_cropped-1]

[H2] What's new at Resilience

scroll

Filter
All

Blog

News

[IMG: Post icon]

May 14, 2026

From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era
Company Culture . In The News

[IMG: Post icon]

November 20, 2025

Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing

[IMG: Post icon]

November 20, 2025

Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian
Cell Therapy . Technology . Resources

[IMG: Post icon]

October 29, 2025

Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
Press Release . Biomanufacturing . Drug Product . Sterile Fill/Finish . In The News . Financing

[IMG: Post icon]

July 11, 2025

How integrated data systems enhance clinical development and manufacturing
Biomanufacturing . Tech Transfer . Technology . Development

[IMG: Post icon]

June 27, 2025

CDMOs Are Making Their Supply Chains More Resilient & Secure
Biomanufacturing . In The News . Development

[IMG: Post icon]

June 05, 2025

Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
Biomanufacturing . Drug Product

[IMG: Post icon]

May 08, 2025

On Demand Webinar:  Fill/Finish Services - Outsourced Pharma Capacity Update
Biomanufacturing . Drug Product . Sterile Fill/Finish . Webinar

[IMG: Post icon]

May 06, 2025

Cell Therapy Innovations: Reducing Costs to Improve Patient Access
Cell Therapy . Biomanufacturing

[IMG: Post icon]

March 28, 2025

Executive Interview: Advancing Therapies That Transform Lives
Company Culture

[IMG: Post icon]

March 26, 2025

Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash
Press Release . Biomanufacturing . Drug Product . In The News . Partnerships

[IMG: Post icon]

January 30, 2025

Presentation: Rapid Multi-Omics Cell Therapy Characterization and QC
Cell Therapy . Technology . Presentation . Resources

[IMG: Post icon]

January 29, 2025

Whitepaper: 3-Day Short Cycle CAR-T Manufacturing Process
Cell Therapy . Technology . White Paper . Resources

[IMG: Post icon]

January 15, 2025

Resilience is proud to support CARGO Therapeutics' novel allogeneic CAR-T cell therapy
Press Release . In The News . Media Coverage

[IMG: Post icon]

January 14, 2025

Presentation: Expedited Cell Therapy QC: Sample in, to QC Report in 48 Hours
Cell Therapy . Technology . Presentation . Resources

[IMG: Post icon]

January 08, 2025

Resilience Partners with Parvus Therapeutics for Development and Manufacturing of PVT401, a Novel Autoimmune Drug Candidate for IBD
Press Release . In The News . Media Coverage

[IMG: Post icon]

December 05, 2024

Resilience Announces Appointment of William S. Marth, RPh., MBA as Chief Executive Officer
Press Release . Company Culture . In The News . Media Coverage

[IMG: Post icon]

November 05, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update - Drug Substance
Biologics . Facilities . Webinar . Presentation . Drug Substance

[IMG: Post icon]

October 28, 2024

Key Steps in the Vaccine Scale-up Journey
Vaccines . Regulatory

[IMG: Post icon]

October 03, 2024

Resilience Secures Funding to Expand Domestic Manufacturing for Critical Pharmaceutical Ingredients
Press Release . Biomanufacturing . In The News . Media Coverage . Government/NGO

[IMG: Post icon]

September 30, 2024

Resilience Appoints Dr. Susan Billings, Chief Commercial Officer
Press Release . Company Culture . In The News . Media Coverage

[IMG: Post icon]

July 10, 2024

Boston, MA: Process & Analytical Development and Manufacturing Facility
Vaccines . Biologics . Facilities . Gene Therapy . Process and Analytical Development . Resources

[IMG: Post icon]

July 01, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update - Fill/Finish
Drug Product . Sterile Fill/Finish

[IMG: Post icon]

June 27, 2024

On-Demand Presentation: Improving cell line development in CHO with a focus on product manufacturability
Biologics . Presentation . Resources

[IMG: Post icon]

June 27, 2024

Meet the Team: Viral Vector Development & Manufacturing
Gene Therapy . Biomanufacturing . Tech Transfer . Company Culture . Process and Analytical Development

[IMG: Post icon]

June 05, 2024

Alachua Campus Tour Video
Government/NGO

[IMG: Post icon]

May 02, 2024

Revised Annex 1 and the Focus on Microbial Control Strategies
Biomanufacturing . Drug Product . Regulatory . Sterile Fill/Finish . Resources

[IMG: Post icon]

April 25, 2024

Starburst Data Rebel Awards: Data Product of the Year
In The News . Awards . Technology

[IMG: Post icon]

March 25, 2024

Building Velocity into Fill/Finish Timelines: Your Guide to Quality and Regulatory Success in the CDMO Space
Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Resources

[IMG: Post icon]

March 07, 2024

On-Demand Webinar: Outsourced Pharma Capacity Update 2024 - Large Molecules
Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development

[IMG: Post icon]

February 23, 2024

On-demand Webinar: Optimize research and delivery of complex medicines using data insights
Webinar . Partnerships . Technology

[IMG: Post icon]

February 20, 2024

Resilience Expands Clinical and Commercial Drug Product Manufacturing Capabilities and Capacities
Press Release . In The News . Partnerships

[IMG: Post icon]

February 19, 2024

Scale Your Vaccine Development with Path-to-PAD
Vaccines . Process and Analytical Development

[IMG: Post icon]

February 13, 2024

How Resilience Is Bringing Forward Thinking to Disrupt the Biomanufacturing Landscape to Increase Access to Medicines
Company Culture

[IMG: Post icon]

February 05, 2024

National Resilience and Taiwan Bio-Manufacturing Corporation Announce Groundbreaking Partnership in Biomanufacturing Innovation
Press Release . In The News . Partnerships

[IMG: Post icon]

January 11, 2024

Successful Development and Manufacturing of Vaccines Containing Aluminum Adjuvants
Vaccines . Sterile Fill/Finish

[IMG: Post icon]

January 04, 2024

Developing New Medicines Through Artificial Intelligence
Technology . Artificial Intelligence . Protein-Engineering

[IMG: Post icon]

January 04, 2024

Resilience to Present at the 42nd Annual J.P. Morgan Healthcare Conference
Press Release . In The News

[IMG: Post icon]

December 21, 2023

The Stage-Gate Model: A Proven Approach to Streamline Biomanufacturing
Tech Transfer . Technology . White Paper . Resources

[IMG: Post icon]

December 20, 2023

Resilience builds lab supply chain tracking platform on AWS
Biomanufacturing . Partnerships . Technology

[IMG: Post icon]

December 12, 2023

On-demand Video: Efficiency Meets Economy: The Power of Single-Use Chromatography in mAb Purification
Biologics

[IMG: Post icon]

December 11, 2023

Resilience Announces Expansion in West Chester
Press Release . In The News . Partnerships

[IMG: Post icon]

November 30, 2023

How digital twins help improve biomanufacturing quality and security
Digital Twins . Technology

[IMG: Post icon]

November 17, 2023

On-demand Video: Idea to Clinic – Aim to Reduce your Manufacturing Timeline by ~30%
Biologics . Biomanufacturing

[IMG: Post icon]

November 07, 2023

Resilience Appoints Bill Marth as President of Services
Press Release . Partnerships

[IMG: Post icon]

October 26, 2023

Accelerating Clinical Timelines of Induced Pluripotent Stem Cells (iPSCs) with Pluristyx
Cell Therapy . Biomanufacturing . In The News . Partnerships

[IMG: Post icon]

October 03, 2023

BridgeBio and Resilience Announce Strategic Multi-Year Partnership
Press Release . Partnerships

[IMG: Post icon]

August 29, 2023

The Challenges and Solutions for Viral Products
Vaccines . Biomanufacturing

[IMG: Post icon]

August 28, 2023

How Early-Phase Companies Can Future-Proof Their Cell Therapies
Cell Therapy . Process and Analytical Development

[IMG: Post icon]

August 28, 2023

Resilience Announces Joint Venture with Lifera in Saudi Arabia
Press Release . Partnerships

[IMG: Post icon]

July 13, 2023

Opening of Resilience's West Coast Cell Therapy PAD Center
Cell Therapy . Biomanufacturing . In The News

[IMG: Post icon]

July 12, 2023

On-Demand Webinar: High-Throughput Process & Analytical Platforms to Accelerate Gene Therapy Scale-Up
Gene Therapy . Process and Analytical Development

[IMG: Post icon]

July 05, 2023

Overcoming Obstacles in Gene Therapy Manufacturing
Gene Therapy . Biomanufacturing

[IMG: Post icon]

May 23, 2023

On-Demand Webinar: Future-Proof Your Aseptic Filling
Webinar

[IMG: Post icon]

May 16, 2023

Resilience Enters Into Strategic Collaboration with Labcorp to Accelerate Cell and Gene Therapies
Cell Therapy . Gene Therapy . Biomanufacturing

[IMG: Post icon]

May 11, 2023

Problem Solving for Aseptic Filling
Drug Product . Sterile Fill/Finish

[IMG: Post icon]

May 08, 2023

On Demand Webinar: Outsourced Pharma Capacity Update-Large Molecules
Vaccines . Biologics . Facilities . Biomanufacturing . Drug Product . Tech Transfer . Process and Analytical Development

[IMG: Post icon]

May 04, 2023

Leveraging Partnerships to Achieve Cell Therapy Success
Cell Therapy . Biomanufacturing

[IMG: Post icon]

April 03, 2023

Master Cell Banks: Laying the Foundation to Final Product Success
Gene Therapy . Biomanufacturing

[IMG: Post icon]

March 24, 2023

Resilience Approved For $410M Financing From The Department Of Defense, In Partnership With The Development Finance Corporation, To Establish Resilient Biomanufacturing Capacity
Press Release . Financing

[IMG: Post icon]

March 23, 2023

Looking Ahead: What Does the Future Have in Store for Nucleic Acid-Based Therapies?
Nucleic Acids

[IMG: Post icon]

February 16, 2023

Resilience Signs Multi-Year Strategic Biomanufacturing Partnership With Leading Pharmaceutical Company
Press Release

[IMG: Post icon]

January 25, 2023

Alachua Biomanufacturing Expansion Video
Vaccines . Biologics . Gene Therapy . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish

[IMG: Post icon]

January 10, 2023

Resilience Announces Equity Investment From Mubadala And Funding Of New Biopharma Manufacturing Facility In The United Arab Emirates
Press Release

[IMG: Post icon]

January 03, 2023

Resilience to Establish Biomanufacturing Partnership with AstraZeneca and Purchase Manufacturing Site
Vaccines . Biologics . Biomanufacturing . Sterile Fill/Finish

[IMG: Post icon]

November 29, 2022

Cell Therapy – What Does It Take To Become a Mainstream Option
Cell Therapy . Biomanufacturing . Resources

[IMG: Post icon]

November 29, 2022

On Demand Drug Substance Manufacturing and Drug Product Fill/Finish Solutions Presentation
Biologics . Biomanufacturing . Drug Product . Tech Transfer . Sterile Fill/Finish . Process and Analytical Development . Webinar

[IMG: Post icon]

November 29, 2022

Resilience To Establish A Biomanufacturing Partnership With AstraZeneca And Purchase AstraZeneca’s Manufacturing Site In West Chester, Ohio
Press Release

[IMG: Post icon]

October 12, 2022

National Resilience Honored By Goldman Sachs For Entrepreneurship
Press Release

[IMG: Post icon]

October 05, 2022

On-Demand Webinar: Establishing a Stage-Gate Approach to Biomanufacturing
Webinar

[IMG: Post icon]

August 23, 2022

Resilience Becomes Biomanufacturing Resource Partner For California Institute For Regenerative Medicine
Press Release

[IMG: Post icon]

August 15, 2022

Resilience Announces Collaboration To Manufacture And Deliver Biotherapeutics For Rare And Complex Conditions
Press Release . Partnerships

[IMG: Post icon]

June 08, 2022

The Parker Institute For Cancer Immunotherapy And Resilience Announce Strategic Alliance To Develop Next-Generation Cancer Therapies
Press Release . Partnerships

[IMG:

Headquarters (Blue Ash, OH)

10901 Kenwood Road Blue Ash, OH 45242

[IMG: Blue Ash]

Cincinnati*

8814 Trade Port DrHamilton, OH 45011, USA
Commercially Licensed Facility

[IMG: site-cincinnati-small]

Toronto*

2585 Meadowpine BlvdMississauga, ON L5N 8H9, Canada
Commercially Licensed Facility

[IMG: site-mississauga-01]

Philadelphia

2900 Potshop LaneEast Norriton PA 19403, USA
Commercial Licensure Coming Soon

[IMG: Philadelphia]

[IMG: RESI-map-10212025]

*Indicates Commercially Licensed Facility

[H2]
Inquiries

[H4]
General Inquiries

+1 888 737 2460
contact@resilience.com

[H4]
Media Contact

Catherine Hanley
catherine.hanley@resilience.com

Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy

Resilience and JobsOhio Announce Continued Partnership and Expansion in Blue Ash, OH

[H1] BLOG

[H2] Featured

[IMG: Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy | featured image]

Press Release

Biomanufacturing

[H3] Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
Read on
[IMG: Forward navigation arrow]

[IMG: Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead | featured image]

Biomanufacturing

Drug Product

[H3] Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Read on
[IMG: Forward navigation arrow]

[H2] Latest

All
News
Webinars
Videos
Articles

Filter by Tags

Biomanufacturing

Cell Therapy

Drug Product

Technology

Biologics

Resources

Sterile Fill/Finish

Vaccines

Process and Analytical Development

Tech Transfer

Gene Therapy

In The News

Webinar

Company Culture

Facilities

Presentation

Partnerships

Development

Regulatory

White Paper

Artificial Intelligence

Awards

Digital Twins

Drug Substance

Financing

Government/NGO

Nucleic Acids

Press Release

Protein-Engineering

[IMG: From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era - featured image]

Company Culture
In The News

[H3] From Complexity to Clarity - Sharpening Focus for Long-Term Performance in a More Demanding CDMO Era
Published by Drug Development & Delivery Resilience has spent the past year reshaping its business with a clear objective: sharpen focus, strengthen...
Read on
[IMG: Forward navigation arrow]

[IMG: Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy - featured image]

Press Release
Biomanufacturing

[H3] Resilience Announces Long-Term Financing of up to $825 Million to Accelerate CDMO Strategy
New Capital from Oak Hill Advisors to Drive Investment in Go-Forward Manufacturing Operations CINCINNATI--(BUSINESS WIRE)--National Resilience...
Read on
[IMG: Forward navigation arrow]

[IMG: Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian - featured image]

Cell Therapy
Technology

[H3] Redefining CAR-T Speed and Strength with DAR-T™: A Conversation with Nicholas Kirian
In this Q&A, Nicholas Kirian, Senior Manager of MSAT, discusses how DAR-T™, an autologous CAR-T platform, is addressing longstanding challenges in...
Read on
[IMG: Forward navigation arrow]

[IMG: How integrated data systems enhance clinical development and manufacturing - featured image]

Biomanufacturing
Tech Transfer

[H3] How integrated data systems enhance clinical development and manufacturing
Published by PharmaVoice In the rapidly evolving landscape of biopharmaceuticals, the integration of robust digital systems has become paramount....
Read on
[IMG: Forward navigation arrow]

[IMG: CDMOs Are Making Their Supply Chains More Resilient & Secure - featured image]

Biomanufacturing
In The News

[H3] CDMOs Are Making Their Supply Chains More Resilient & Secure
Published byDrug Development & Delivery Growing R&D activities, personalized medicines, large-scale production of biologics, and access to new...
Read on
[IMG: Forward navigation arrow]

[IMG: Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead - featured image]

Biomanufacturing
Drug Product

[H3] Navigating the Evolving Landscape of Fill/Finish: Trends, Challenges, and What’s Ahead
A Q&A with Nithin Stephen As the pharmaceutical and biotech industries continue to innovate at a rapid pace, the demand for fill/finish capabilities...
Read on
[IMG: Forward navigation arrow]

1

2

3

4

5

[IMG: resi-link-arrow]

[IMG: Biomanufacturing Scientists]
[H4] Audacious. Agile. Advanced. Getting the best medicines to patients faster demands everyone bring their “A game.” We’re ready to put our collective talent and resources to work, freeing you from the obstacles impeding the success of your novel therapy.

[H2]
YOUR TOMORROW STARTS TODAY

Bold ideas deserve to be supported in bold ways. What was clear before the pandemic is even more clear today: the status quo won’t do. The world needs more. Resilience was created to deliver more – through capabilities, services, and resources acutely aligned to your most pressing needs.

[H2]
INCUBATE

Whether you are a leading research institute, academic, emerging biotech or established pharma — Resilience can help incubate your new therapy, drug manufacturing technology or process improvement project. We provide access to state-of-the-art equipment and a vast team of highly specialized industry experts to help you discover where your emerging discoveries can lead.

[IMG: Biopharmaceutical Manufacturing Experts]

[H2]
COLLABORATE

We’re prepared to invest our resources in smart, promising science in any stage of development. Because at every stage, there are problems to be solved, levers to be pulled, and inspirations and energy to be harnessed. Yet we understand that none of that will happen without sufficient resources. You’ll have a committed team at your side equipped with the know-how to advance your work further, faster.

[IMG: Biopharmaceutical Manufacturing Specialists]

[H2]
MANUFACTURE

When you work with us, you’ll access our interconnected network, specifically designed to address the breakpoints inherent in traditional biomanufacturing so that no single point of failure will set you back. Throughout pre-clinical, clinical, and commercial cGMP manufacturing, our uniform operation model delivers excellence across all of our sites.

[IMG: Biomanufacturing Scientist]

[H2]
Keep Your Science in Stride

[H5] How can a biomanufacturing partnership help keep your discovery rolling? Put our best to work in support of yours. Let’s take the first step forward together.

[IMG: Connect with the Resilience Team]